UHRF1 and cancer: Two groups independently discovered very similar inhibitors targeting the TTD (Tandem Tudor Domain) of UHRF1 [99,100], and another an inhibitor of the PHD (Plant HomeoDomain) finger that is cell-permeable [101]; further chemical and experimental work will be necessary to determine whether these molecules might be useful for cancer treatment.